KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Assets (2016 - 2025)

Pacific Biosciences Of California has reported Return on Assets over the past 15 years, most recently at 0.69% for Q4 2025.

  • Quarterly results put Return on Assets at 0.69% for Q4 2025, down 46.0% from a year ago — trailing twelve months through Dec 2025 was 0.69% (down 46.0% YoY), and the annual figure for FY2025 was 0.53%, down 33.0%.
  • Return on Assets for Q4 2025 was 0.69% at Pacific Biosciences Of California, down from 0.62% in the prior quarter.
  • Over the last five years, Return on Assets for PACB hit a ceiling of 0.01% in Q1 2021 and a floor of 0.69% in Q4 2025.
  • Median Return on Assets over the past 5 years was 0.17% (2023), compared with a mean of 0.26%.
  • Biggest five-year swings in Return on Assets: surged 54bps in 2021 and later plummeted -46bps in 2025.
  • Pacific Biosciences Of California's Return on Assets stood at 0.02% in 2021, then tumbled by -761bps to 0.18% in 2022, then increased by 4bps to 0.17% in 2023, then plummeted by -36bps to 0.23% in 2024, then plummeted by -201bps to 0.69% in 2025.
  • The last three reported values for Return on Assets were 0.69% (Q4 2025), 0.62% (Q3 2025), and 0.62% (Q2 2025) per Business Quant data.